These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10530773)
1. Effects of gadolinium ions upon rat prostatic cancer cell lines of markedly different metastatic potential. Verrall J; Fraser SP; Djamgoz MB Cancer Lett; 1999 Oct; 145(1-2):79-83. PubMed ID: 10530773 [TBL] [Abstract][Full Text] [Related]
2. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. Fraser SP; Salvador V; Manning EA; Mizal J; Altun S; Raza M; Berridge RJ; Djamgoz MB J Cell Physiol; 2003 Jun; 195(3):479-87. PubMed ID: 12704658 [TBL] [Abstract][Full Text] [Related]
3. Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Fraser SP; Ding Y; Liu A; Foster CS; Djamgoz MB Cell Tissue Res; 1999 Mar; 295(3):505-12. PubMed ID: 10022970 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of dunning rat prostate tumor fluid on proliferation of the metastatic MAT-LyLu cell line. Bugan I; Altun S Asian Pac J Cancer Prev; 2015; 16(2):831-6. PubMed ID: 25684533 [TBL] [Abstract][Full Text] [Related]
5. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers. Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302 [TBL] [Abstract][Full Text] [Related]
9. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Mohler JL; Levy F; Sharief Y Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730 [TBL] [Abstract][Full Text] [Related]
10. Promotion of metastases by tumor necrosis factor in rats bearing Dunning R3327 MAT-LyLu prostatic cancer. Iizumi T; Yazaki T; Umeda T; Soma GI Urol Int; 1993; 51(2):85-8. PubMed ID: 8351760 [TBL] [Abstract][Full Text] [Related]
11. Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-lines. Bashir I; Sikora K; Abel P; Foster CS Int J Cancer; 1994 Jun; 57(5):719-26. PubMed ID: 7910810 [TBL] [Abstract][Full Text] [Related]
12. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells. Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479 [TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline. Wenger AS; Mickey DD; Hall M; Silverman LM; Mickey GH; Fried FA J Urol; 1984 Jun; 131(6):1232-6. PubMed ID: 6539387 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Powell CT; Gschwend JE; Fair WR; Brittis NJ; Stec D; Huryk R Cancer Res; 1996 Sep; 56(18):4137-41. PubMed ID: 8797581 [TBL] [Abstract][Full Text] [Related]
15. Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Miekus K; Czernik M; Sroka J; Czyz J; Madeja Z Biol Cell; 2005 Dec; 97(12):893-903. PubMed ID: 15907197 [TBL] [Abstract][Full Text] [Related]
16. Prediction of metastatic potential by cancer cell motility in the Dunning R-3327 prostatic adenocarcinoma in vivo model. Doyle GM; Sharief Y; Mohler JL J Urol; 1992 Feb; 147(2):514-8. PubMed ID: 1732634 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Lokeshwar BL; Selzer MG; Zhu BQ; Block NL; Golub LM Int J Cancer; 2002 Mar; 98(2):297-309. PubMed ID: 11857423 [TBL] [Abstract][Full Text] [Related]
18. Biometric assessment of prostate cancer's metastatic potential. Cooper CR; Emmett N; Harris-Hooker S; Patterson R; Cooke DB World J Urol; 1994; 12(6):304-7. PubMed ID: 7881466 [TBL] [Abstract][Full Text] [Related]
19. The effect of hydrazine sulfate on prostate cancer growth. Kamradt JM; Pienta KJ Oncol Rep; 1998; 5(4):919-21. PubMed ID: 9625846 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. Pienta KJ; Naik H; Akhtar A; Yamazaki K; Replogle TS; Lehr J; Donat TL; Tait L; Hogan V; Raz A J Natl Cancer Inst; 1995 Mar; 87(5):348-53. PubMed ID: 7853416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]